Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (3y) (2020 - 2026)
Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 36.44 Bn | 32.71 Bn | 1.97 Bn | 8.16% |
| 2 | Zoetis | 33.18 Bn | 31.24 Bn | 1.62 Bn | 26.15% |
| 3 | United Therapeutics | 23.36 Bn | 21.20 Bn | 648.10 Mn | 75.05% |
| 4 | Neurocrine Biosciences | 15.90 Bn | 14.58 Bn | 800.70 Mn | -129.09% |
| 5 | Aurora Cannabis | 15.07 Bn | 14.99 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.06 Bn | 11.63 Bn | 785.00 Mn | -2.94% |
| 7 | Hims & Hers Health | 8.09 Bn | 7.34 Bn | 396.79 Mn | -55.44% |
| 8 | Alkermes | 7.47 Bn | 6.96 Bn | -116.06 Mn | -212.48% |
| 9 | Lantheus Holdings | 6.69 Bn | 6.19 Bn | 230.92 Mn | 37.22% |
| 10 | Liquidia | 6.26 Bn | 6.03 Bn | 121.79 Mn | -98.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.16% |
| Dec 31, 2025 | -0.60% |
| Sep 30, 2025 | -2.80% |
| Jun 30, 2025 | 9.65% |
| Mar 31, 2025 | 7.68% |
| Dec 31, 2024 | -6.36% |
| Sep 30, 2024 | -2.37% |
| Jun 30, 2024 | -28.21% |
| Mar 31, 2024 | -34.31% |
| Dec 31, 2023 | 28.76% |
| Sep 30, 2023 | 5.43% |
| Jun 30, 2023 | -1.19% |
| Mar 31, 2023 | -10.44% |
| Dec 31, 2022 | -26.90% |
| Sep 30, 2022 | -13.10% |
| Jun 30, 2022 | -25.28% |
| Mar 31, 2022 | -16.04% |
| Dec 31, 2021 | 49.25% |
| Sep 30, 2021 | -6.02% |
| Jun 30, 2021 | 5.81% |